>>> US Research Calls

Research Calls I
  • Upgrades:
    • Arthur J. Gallagher (AJG) upgraded to Buy from Neutral at UBS, tgt $250
    • Brady (BRC) upgraded to Buy from Neutral at Sidoti, tgt $103
    • FuelCell Energy (FCEL) upgraded to Buy from Hold at Canaccord, tgt $30
    • Jumia Technologies (JMIA) upgraded to Buy from Sell at Aletheia, tgt $7.50
    • PAR Technology (PAR) upgraded to Neutral from Underweight at JPMorgan, tgt $16
    • Toll Brothers (TOL) upgraded to Outperform from Market Perform at Keefe Bruyette, tgt $161
    • West Pharmaceutical (WST) upgraded to Overweight from Equal Weight at Barclays, tgt $400
  • Downgrades:
    • Equity Residential (EQR) downgraded to Sector Perform from Outperform at RBC Capital, tgt $70
    • Ingredion (INGR) downgraded to Perform from Outperform at Oppenheimer
    • Lennar (LEN) downgraded to Underperform from Market Perform at Keefe Bruyette, tgt $86
  • Others:
    • Cerebras Systems (CBRS) initiated with a Buy at Craig-Hallum, tgt $325
    • Enliven Therapeutics (ELVN) initiated with a Buy at Stifel, tgt $60
    • FrontView REIT (FVR) initiated with a Strong Buy at Raymond James, tgt $22
    • Gold.com (GOLD) initiated with a Buy at Canaccord, tgt $70
    • International Flavors & Fragrances (IFF) initiated with a Buy at Benchmark, tgt $100
    • Grand Canyon Education (LOPE) initiated with a Buy at Truist, tgt $100
    • LSI Industries (LYTS) initiated with an Outperform at Oppenheimer, tgt $30
    • Magnite (MGNI) initiated with a Buy at BTIG, tgt $20
    • Park Aerospace (PKE) initiated with an Outperform at Citizens, tgt $42
    • PTC Therapeutics (PTCT) assumed with a Buy from Neutral at Citi, tgt $108
    • Ralliant (RAL) assumed with an Outperform at Evercore ISI, tgt $80
    • Spruce Biosciences (SPRB) initiated with a Buy at JonesResearch, tgt $135
    • WPP (WPP) initiated with a Buy at Berenberg